Ernährung beim Lipödem

Das Lipödem wurde lange Zeit als Erkrankung betrachtet, die nicht durch Ernährung oder Sport beeinflusst werden kann. Jüngere Publikationen über Studien und Fallberichte deuten inzwischen darauf hin, dass Ernährungsinterventionen durchaus positive Effekte auf die Symptome und die Lebensqualität von Lipödem-Patientinnen haben können. Ziele sind einerseits die Erhaltung oder, falls nötig, die Erreichung eines gesunden Körpergewichts und einer guten Körperzusammensetzung, andererseits die Reduktion von Schmerzen und Beschwerden. Ernährungsformen mit deutlich bis stark reduziertem Kohlenhydratanteil (Low Carb, ketogene Ernährung) zeigen dabei in den Studien im Vergleich zu anderen Ernährungsformen deutliche Vorteile, nicht nur in Bezug auf das Gewichtsmanagement, sondern auch auf die Reduktion von Schmerzen und anderen Symptomen.

Abstract

The lipedema has long been considered a condition that cannot be influenced by diet or exercise. However, recent publications on studies and case reports suggest that dietary interventions can indeed have positive effects on the symptoms and quality of life of lipedema patients. The goals are, on one hand, to maintain or, if necessary, achieve a healthy body weight and good body composition, and on the other hand, to reduce pain and discomfort. Diets with significantly to strongly reduced carbohydrates (such as Low Carb and ketogenic diets) have shown considerable advantages in studies compared to other dietary approaches, not only in terms of weight management but also in the reduction of pain and other symptoms

Schlüsselwörter

Lipödem - Ernährung - anti-inflammatorische Ernährung - ketogene Ernährung

Keywords

lipoedema - nutrition - anti-inflammatory diet - ketogenic diet

Publication History

Received: 09 April 2025

Accepted after revision: 04 August 2025

Article published online:
05 September 2025

• Literatur

• 1 Warren AG, Janz BA, Borud LJ. et al. Evaluation and management of the fat leg syndrome. Plast Reconstr Surg 2007; 119: 9e-15e
• 2 Faerber G, Cornely M, Daubert C. et al. S2k guideline lipedema. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 2024; 1-13
• 3 Deutsche Gesellschaft für Phlebologie und Lymphologie e.V.. S2k Leitlinie Lipödem 2024. AWMF Registernummer 037–12. www.awmf.org/leitlinien/detai/Il037–12.html
• 4 Erbacher G, Bertsch T. Lipoedema and Pain: What is the role of the psyche? – Results of a pilot study with 150 patients with Lipoedema. Phlebologie 2020; 49: 305-316
• 5 Forner-Cordero I, Pérez-Pomares MV, Forner A. et al. Prevalence of clinical manifestations and orthopedic alterations in patients with lipedema: A prospective cohort study. Lymphology 2021; 54: 170-181
• 6 Brenner E, Forner-Cordero I, Faerber G. et al. Body mass index vs. waist-to-height-ratio in patients with lipohyperplasia dolorosa (vulgo lipedema). J Dtsch Dermatol Ges 2023;
• 7 Stutz J. Lipödem: Ursache für schwerwiegende Essstörungen. Phlebologie 2013; 5: A10-A11
• 8 Szél E, Kemény L, Groma G. et al. Pathophysiological dilemmas of lipedema. Med Hypotheses 2014; 83: 599-606
• 9 Annunziata G, Paoli A, Manzi V. et al. The Role of Physical Exercise as a Therapeutic Tool to Improve Lipedema: A Consensus Statement from the Italian Society of Motor and Sports Sciences (Società Italiana di Scienze Motorie e Sportive, SISMeS) and the Italian Society of Phlebology (Società Italiana di Flebologia, SIF). Current Obesity Reports
• 10 Paoli A. The Influence of Physical Exercise, Ketogenic Diet, and Time-Restricted Eating on De Novo Lipogenesis: A Narrative Review. Nutrients 2025; 17: 663
• 11 Claussen M, Friese G, Theis S. Ambulante Gewichtsreduktion durch Mahlzeiten-Ersatz-Therapie in der ärztlichen Praxis: 2-Jahres-Ergebnisse einer nicht kontrollierten Beobachtungsstudie. Aktuelle Ernährungsmedizin 2022; 47: 122-134
• 12 Ebbeling CB, Swain JF, Feldman HA. et al. Effects of dietary composition on energy expenditure during weight-loss maintenance. JAMA 2012; 307: 2627-2634
• 13 Larsen TM, Dalskov S-M, van Baak M. et al. Diets with high or low protein content and glycemic index for weight-loss maintenance. N Engl J Med 2010; 363: 2102-2113
• 14 Ditschuneit HH, Flechtner-Mors M, Johnson TD. et al. Metabolic and weight-loss effects of a long-term dietary intervention in obese patients. Am J Clin Nutr 1999; 69: 198-204
• 15 Ross Middleton KM, Patidar SM, Perri MG. The impact of extended care on the long-term maintenance of weight loss: a systematic review and meta-analysis. Obes Rev 2012; 13: 509-517
• 16 Blüher M, Fasshauer M, Tönjes A. et al. Association of interleukin6, C-reactive protein, interleukin-10 and adiponectin plasma concentrations with measures of obesity, insulin sensitivity and glucose metabolism. Exp Clin Endocrinol Diabetes 2005; 113: 534537
• 17 Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology 2007; 132: 2169-2180
• 18 Feinman RD, Pogozelski WK, Astrup A. et al. Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base. Nutrition 2015; 31: 1-13
• 19 Al-Ghadban S, Cromer W, Allen M. et al. Dilated Blood and Lymphatic Microvessels, Angiogenesis, Increased Macrophages, and Adipocyte Hypertrophy in Lipedema Thigh Skin and Fat Tissue. J Obes 2019; 8747461
• 20 Felmerer G, Stylianaki A, Hägerling R. et al. Adipose Tissue Hypertrophy, An Aberrant Biochemical Profile and Distinct Gene Expression in Lipedema. J Surg Res 2020; 253: 294-303
• 21 Felmerer G, Stylianaki A, Hollmén M. et al. Increased levels of VEGF-C and macrophage infiltration in lipedema patients without changes in lymphatic vascular morphology. Scientific Reports 2020; 10: 10947
• 22 Nono Nankam P, Cornely M, Klöting N. et al. Is subcutaneous adipose tissue expansion in people living with lipedema healthier and reflected by circulating parameters?. Frontiers in Endocrinology 2022; 13
• 23 Cornely M, Faerber G, Hüttinger N. et al. Neues zur Lipohyperplasia dolorosa (Lipödem). JDDG: Journal der Deutschen Dermatologischen Gesellschaft 2025; 23: 29-36
• 24 Faerber G. Antiinflammatorische Ernährung, was ist das und was bringt sie uns beim Lipödem?. Vasomed 2017; 29: 228-229
• 25 Faerber G. Adipositas und chronische Inflammation bei phlebologischen und lymphologischen Erkrankungen. Phlebologie 2018; 47: 55-65
• 26 Cannataro R, Cione E. Lipedema and Nutrition: What’s the Link?. Acta Scientifci Nutritional Health 2020; 4: 86-89
• 27 Amato ACM, Benitti DA. Lipedema Can Be Treated Non-Surgically: A Report of 5 Cases. Am J Case Rep 2020; 22: e934406
• 28 Di Renzo L, Cinelli G, Romano L. et al. Potential Effects of a Modified Mediterranean Diet on Body Composition in Lipoedema. Nutrients 2021; 13
• 29 Lundanes J, Nes VF, Aakervik O. et al. Changes in Cytokines and Fibrotic Growth Factors after Low-Carbohydrate or Low-Fat Low-Energy Diets in Females with Lipedema. Curr Dev Nutr 2025; 9: 104571
• 30 Keith L, Seo CA, Rowsemi C. et al. Ketogenic diet as a potential intervention for lipedema. Med Hypotheses 2021; 146: 110435
• 31 Cannataro R, Michelini S, Ricolfi L. et al. Management of Lipedema with Ketogenic Diet: 22-Month Follow-Up. Life (Basel) 2021; 11
• 32 Verde L, Camajani EA, Annunciata G. Ketogenic Diet: A Nutritional Therapeutic Tool for Lipedema. Current Obesity Reports 2023;
• 33 Jeziorek M, Szuba A, Kujawa K. et al. The Effect of a Low-Carbohydrate, High-Fat Diet versus Moderate-Carbohydrate and Fat Diet on Body Composition in Patients with Lipedema. Diabetes Metab Syndr Obes 2022; 15: 2545-2561
• 34 Jeziorek M, Szuba A, Sowicz M. et al. The Effect of a Low-Carbohydrate High-Fat Diet on Laboratory Parameters in Women with Lipedema in Comparison to Overweight/Obese Women. Nutrients 2023; 15
• 35 Jeziorek M, Chachaj A, Sowicz M. et al. The Benefits of Low-Carbohydrate, High-Fat (LCHF) Diet on Body Composition, Leg Volume, and Pain in Women with Lipedema. J Obes 2023; 5826630
• 36 Sørlie V, De Soysa AK, Hyldmo AsA. et al. Effect of a ketogenic diet on pain and quality of life in patients with lipedema: The LIPODIET pilot study. Obes Sci Pract 2022; 8: 483-493
• 37 Lundanes J, Sandnes F, Gjeilo KH. et al. Effect of a low-carbohydrate diet on pain and quality of life in female patients with lipedema: a randomized controlled trial. Obesity (Silver Spring) 2024; 32: 1071-1082
• 38 Lundanes J, Gårseth M, Taylor S. et al. The effect of a low-carbohydrate diet on subcutaneous adipose tissue in females with lipedema. Front Nutr 2024; 11: 1484612
• 39 Lundanes J, Storliløkken GE, Solem MS. et al. Gastrointestinal hormones and subjective ratings of appetite after low-carbohydrate vs low-fat low-energy diets in females with lipedema – A randomized controlled trial. Clin Nutr ESPEN 2025; 65: 16-24
• 40 Cummings DE, Weigle DS, Scott Frayo R. Plasma Ghrelin Levels after Diet-Induced Weight Loss or Gastric Bypass Surgery. N Engl J Med 2002; 346: 1623-1630
• 41 Feinman RD, Pogozelski WK, Astrup A. et al. Dietary carbohydrate restriction as the first approach in diabetes management: Critical review and evidence base. Nutrition 2015; 31: 1-13
• 42 Dibaise JK, Zhang H, Crowell MD. et al. Gut Microbiota and Its Possible Relationship With Obesity. Mayo Clinic Proceedings 2008; 83: 460-469
• 43 Schoeller DA, Buchholz AC. Energetics of obesity and weight control: does diet composition matter?. J Am Diet Assoc 2005; 105: 524-528
• 44 Weigle DS, Breen DA, Matthys CC. A high protein diet induces sustained reduction in appetite, ad libitum caloric intake and body weight despite compensatory diurnal changes in plasma leptin and ghrelin concentrations. Am J Clin Nutr 2005; 82: 41-48
• 45 Rolls BJ, Hetherington M, Burley VJ. The specificity of satiety: The influence of foods of different macronutrient content on the development of satiety. PhysiolBehav 1988; 43: 145-153
• 46 Westman EC, Feinman RD, Mavropoulos JC. et al. Low-carbohydrate nutrition and metabolism. The American journal of clinical nutrition 2007; 86: 276-284
• 47 Westman EC, Mavropoulos J, Yancy WS. A review of low-carbohydrate ketogenicdiets. Curr Atheroscler Rep 2003; 5: 476-483
• 48 Noakes T. Low-carbohydrate and high-fat intake can manage obesity and associated conditions: Occasional survey. South African Medical Journal 2013; 103: 826-830
• 49 Yancy WS, Olsen MK, Guyton JR. et al. A Low- Carbohydrate, Ketogenic Diet versus a Low-Fat Diet ToTreat Obesity and Hyperlipidemia: A Randomized, Controlled Trial. Ann Intern Med 2004; 140: 769-777
• 50 Youm YH, Nguyen KY, Grant RW. The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome–mediated inflammatory disease. Nature Medicine 2015; 21: 263-269
• 51 Volek JS, Westman EC. Very-low-carbohydrate weight-loss diets revisited. Clin J Med 2002; 69: 849, 853, 856-858